EPO Patent Publication: Compositions for Treating Cancers

The European Patent Office has published patent application EP2026030629A1 concerning compositions and methods for treating cancers. The publication date is March 18, 2026, and it includes various International Patent Classification codes related to pharmaceutical compositions and medical treatments.

Patent EP2026030180A1: Method for Optimizing Vero Cell Growth

The European Patent Office has published patent application EP2026030180A1 concerning a method for optimizing Vero cell growth. This publication relates to biotechnology and intellectual property within the pharmaceutical sector.

EPO Patent EP2026030145A1 on Recombinant Vaccinia Vectors

The European Patent Office has published patent application EP2026030145A1 concerning recombinant vaccinia vectors and methods of use. The publication date is March 18, 2026. The inventors have not yet been designated.

EPO Patent Publication EP2026029176A1: Anti-Integrin α8β1 Antibody

The European Patent Office (EPO) has published patent application EP2026029176A1 concerning an anti-integrin α8β1 antibody. The publication date is March 18, 2026, and the inventors have not yet been designated.

EPO Patent Publication: HPV Vaccines (EP2026030253A1)

The European Patent Office (EPO) has published patent application EP2026030253A1 concerning Human Papillomavirus (HPV) vaccines. The publication date is March 18, 2026, and it includes IPC classifications related to vaccines and biotechnology.

EPO Patent: Cardiomyopathy Treatment With ATF4 Gene Therapy

The European Patent Office has published patent application EP2026030234A2 concerning a gene therapy for the prevention and treatment of cardiomyopathy-related diseases using ATF4. The publication date is March 18, 2026, and it covers designated states within the European Union.

EPO Patent Publication: Gene Therapy for Beta-Hemoglobinopathies

The European Patent Office has published a patent application (EP2026029716A1) concerning a polynucleotide construct for gene therapy of beta-hemoglobinopathies. The publication date is March 18, 2026, and it includes IPC classifications related to biotechnology and medical treatments.

Microorganism Patent for Producing Pantothenic Acid or Tryptophan

The European Patent Office has published a patent (EP2026029587A1) for a microorganism modified with a foreign lipoate metabolic gene. This microorganism is intended for the production of pantothenic acid or tryptophan. The publication date is March 18, 2026.

Pandemic Influenza Vaccine Patent Application EP2026029847A1

The European Patent Office has published patent application EP2026029847A1 concerning methods and compositions for a pandemic influenza vaccine. The publication date is March 18, 2026, and the inventors have not yet been designated.

EPO Patent Application EP2026029836A1 Published: Probiotic Compositions

The European Patent Office (EPO) has published patent application EP2026029836A1 concerning probiotic compositions with bile acid deconjugation and dehydroxylation properties. The publication date is March 18, 2026, and it includes inventors and IPC classifications related to pharmaceutical and biotechnological applications.